Arch Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Arch Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q4 2023.
  • Arch Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $846K.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.85M, a 2.79% decline from 2022.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.94M, a 59.6% decline from 2021.
  • Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $7.27M, a 90% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $846K +$932K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q4 2022 -$86.3K -$86.3K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q4 2021 $0 -$1.05M -100% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q4 2020 $1.05M -$1.12M -51.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q4 2019 $2.17M +$2.13M +6589% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q4 2018 $32.4K -$31K -48.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-01-30
Q4 2017 $63.4K -$67.2K -51.4% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q4 2016 $131K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q4 2014 $800K -$200K -20% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-09
Q4 2013 $1M +$875K +700% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q4 2012 $125K +$125K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q1 2012 $0 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $0 Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.